219 related articles for article (PubMed ID: 32481718)
1. Intrinsic Dissolution Rate Profiling of Poorly Water-Soluble Compounds in Biorelevant Dissolution Media.
Teleki A; Nylander O; Bergström CAS
Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32481718
[TBL] [Abstract][Full Text] [Related]
2. Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds.
Andersson SBE; Alvebratt C; Bergström CAS
Pharm Res; 2017 Sep; 34(9):1805-1816. PubMed ID: 28620887
[TBL] [Abstract][Full Text] [Related]
3. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
4. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
5. Dissolution behavior of various drugs in different FaSSIF versions.
Klumpp L; Leigh M; Dressman J
Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.
Oktay AN; Polli JE
Eur J Pharm Sci; 2024 May; 196():106746. PubMed ID: 38499112
[TBL] [Abstract][Full Text] [Related]
7. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
8. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
9. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
10. Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs.
Andersson SBE; Alvebratt C; Bevernage J; Bonneau D; da Costa Mathews C; Dattani R; Edueng K; He Y; Holm R; Madsen C; Müller T; Muenster U; Müllertz A; Ojala K; Rades T; Sieger P; Bergström CAS
J Pharm Sci; 2016 Sep; 105(9):2864-2872. PubMed ID: 27112289
[TBL] [Abstract][Full Text] [Related]
11. An interlaboratory investigation of intrinsic dissolution rate determination using surface dissolution.
Etherson K; Dunn C; Matthews W; Pamelund H; Barragat C; Sanderson N; Izumi T; Mathews CDC; Halbert G; Wilson C; McAllister M; Mann J; Østergaard J; Butler J; Khadra I
Eur J Pharm Biopharm; 2020 May; 150():24-32. PubMed ID: 32061919
[TBL] [Abstract][Full Text] [Related]
12. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Physicochemical Properties of Two Weakly Basic Drugs and the Precipitates Obtained from Biorelevant Media.
Zhang M; Wu B; Zhang S; Wang L; Hu Q; Liu D; Chen X
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214062
[TBL] [Abstract][Full Text] [Related]
14. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
[TBL] [Abstract][Full Text] [Related]
15. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
16. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
17. Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.
Long CM; Tang K; Chokshi H; Fotaki N
AAPS PharmSciTech; 2019 Feb; 20(3):113. PubMed ID: 30761437
[TBL] [Abstract][Full Text] [Related]
18. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
Pawar G; Wu F; Zhao L; Fang L; Burckart GJ; Feng K; Mousa YM; Al Shoyaib A; Jones MC; Batchelor HK
AAPS J; 2023 Jun; 25(4):67. PubMed ID: 37386339
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.
Galia E; Nicolaides E; Hörter D; Löbenberg R; Reppas C; Dressman JB
Pharm Res; 1998 May; 15(5):698-705. PubMed ID: 9619777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
